BD Pledges $110M to Expand Nebraska Syringe Manufacturing

BD pledges $110M to expand Nebraska syringe manufacturing

Becton, Dickinson and Co. plans to invest more than $110 million to expand a prefilled flush syringe manufacturing facility in Nebraska. According to BD, the plan aims to better meet growing demand for biologic drugs. The Franklin Lakes-based medical technology company announced the investment in a Jan. 13 press release. The company said the capital will go toward establishing production of its BD Neopak Glass Prefillable Syringes at the 76-year…

BD to invest $110M to support prefilled syringe production

The Neopak XtraFlow glass prefillable syringe. [Image courtesy of BD]BD (NYSE:BDX) announced today that it invested $110 million to expand its production of prefillable syringes in Columbus, Nebraska. Franklin Lakes, New Jersey-based BD aims to expand prefillable syringe production to accelerate biologic and GLP-1 drug delivery and support pharmaceutical reshoring in the U.S. The investment brings the company’s Neopak glass prefillable syringe p…